SAHA SAURABH bought CNTA
July 21, 2025 · Form 4 insider transaction
SAHA SAURABH bought 55,000 shares of Centessa Pharmaceuticals plc at $3.85 per share, a transaction worth $211.8K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 0 days after the transaction.
Direction
Acquired (buy-side)
Shares
55,000
Price
$3.85
Total value
$211.8K
InsiderSAHA SAURABH
Role—
SecurityOrdinary Shares
Transaction codeM: Option exercise
Transaction dateJuly 21, 2025
Filing dateJuly 21, 2025
Shares owned after276,017
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.